What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?

被引：51

作者：

Banach, Maciej ^{[1
,2
,3
]}

Penson, Peter E. ^{[4
]}

机构：

[1] Med Univ Lodz, Dept Hypertens, Zeromskiego 113, PL-90549 Lodz, Poland

[2] PMMHRI, Lodz, Poland

[3] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland

[4] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool, Merseyside, England

来源：

CARDIOVASCULAR RESEARCH | 2019年 / 115卷 / 03期

关键词：

ARTERY CALCIUM SCORE; HEART-DISEASE; EFFICACY; SAFETY; EZETIMIBE; THERAPY;

D O I：

10.1093/cvr/cvy301

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E26 / E31

页数：6

共 27 条

[1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[2]

Banach M., 2018, EAS ADV COURS CLIN E

[3] The Role of Nutraceuticals in Statin Intolerant Patients [J].

Banach, Maciej ;

Patti, Angelo Maria ;

Giglio, Rosaria Vincenza ;

Cicero, Arrigo F. G. ;

Atanasov, Atanas G. ;

Bajraktari, Gani ;

Bruckert, Eric ;

Descamps, Olivier ;

Djuric, Dragan M. ;

Ezhov, Marat ;

Fras, Zlatko ;

von Haehling, Stephan ;

Katsiki, Niki ;

Langlois, Michel ;

Latkovskis, Gustavs ;

Mancini, G. B. John ;

Mikhailidis, Dimitri P. ;

Mitchenko, Olena ;

Moriarty, Patrick M. ;

Muntner, Paul ;

Nikolic, Dragana ;

Panagiotakos, Demosthenes B. ;

Paragh, Gyorgy ;

Paulweber, Bernhard ;

Pella, Daniel ;

Pitsavos, Christos ;

Reiner, Zeljko ;

Rosano, Giuseppe M. C. ;

Rosenson, Robert S. ;

Rysz, Jacek ;

Sahebkar, Amirhossein ;

Serban, Maria-Corina ;

Vinereanu, Dragos ;

Vrablik, Michal ;

Watts, Gerald F. ;

Wong, Nathan D. ;

Rizzo, Manfredi .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (01) :96-118

[4] Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel [J].

Banach, Maciej ;

Rizzo, Manfredi ;

Toth, Peter P. ;

Farnier, Michel ;

Davidson, Michael H. ;

Al-Rasadi, Khalid ;

Aronow, Wilbert S. ;

Athyros, Vasilis ;

Djuric, Dragan M. ;

Ezhov, Marat V. ;

Greenfield, Robert S. ;

Hovingh, G. Kees ;

Kostner, Karam ;

Serban, Corina ;

Lighezan, Daniel ;

Fras, Zlatko ;

Moriarty, Patrick M. ;

Muntner, Paul ;

Goudev, Assen ;

Ceska, Richard ;

Nicholls, Stephen J. ;

Broncel, Marlena ;

Nikolic, Dragana ;

Pella, Daniel ;

Puri, Raman ;

Rysz, Jacek ;

Wong, Nathan D. ;

Bajnok, Laszlo ;

Jones, Steven R. ;

Ray, Kausik K. ;

Mikhailidis, Dimitri P. .

ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) :1-23

[5] PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease [J].

Bittner, Vera A. ;

Giugliano, Robert P. ;

Brinton, Eliot A. ;

Guyton, John R. .

JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (04) :835-843

[6] Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction [J].

Bohula, Erin A. ;

Bonaca, Marc P. ;

Braunwald, Eugene ;

Aylward, Philip E. ;

Corbalan, Ramon ;

De Ferrari, Gaetano M. ;

He, Ping ;

Lewis, Basil S. ;

Merlini, Piera A. ;

Murphy, Sabina A. ;

Sabatine, Marc S. ;

Scirica, Benjamin M. ;

Morrow, David A. .

CIRCULATION, 2016, 134 (04) :304-+

[7] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].

Cannon, Christopher P. ;

Blazing, Michael A. ;

Giugliano, Robert P. ;

McCagg, Amy ;

White, Jennifer A. ;

Theroux, Pierre ;

Darius, Harald ;

Lewis, Basil S. ;

Ophuis, Ton Oude ;

Jukema, J. Wouter ;

De Ferrari, Gaetano M. ;

Ruzyllo, Witold ;

De Lucca, Paul ;

Im, KyungAh ;

Bohula, Erin A. ;

Reist, Craig ;

Wiviott, Stephen D. ;

Tershakovec, Andrew M. ;

Musliner, Thomas A. ;

Braunwald, Eugene ;

Califf, Robert M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397

[8] A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels [J].

Cao, Ye-Xuan ;

Liu, Hui-Hui ;

Li, Sha ;

Li, Jian-Jun .

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) :87-97

[9] Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial [J].

Giugliano, Robert P. ;

Pedersen, Terje R. ;

Park, Jeong-Gun ;

De Ferrari, Gaetano M. ;

Gaciong, Zbigniew A. ;

Ceska, Richard ;

Toth, Kalman ;

Gouni-Berthold, Ioanna ;

Lopez-Miranda, Jose ;

Schiele, Francois ;

Mach, Francois ;

Ott, Brian R. ;

Kanevsky, Estelle ;

Pineda, Armando Lira ;

Somaratne, Ransi ;

Wasserman, Scott M. ;

Keech, Anthony C. ;

Sever, Peter S. ;

Sabatine, Marc S. .

LANCET, 2017, 390 (10106) :1962-1971

[10] Cognitive Function in a Randomized Trial of Evolocumab [J].

Giugliano, Robert P. ;

Mach, Francois ;

Zavitz, Kenton ;

Kurtz, Christopher ;

Im, Kyungah ;

Kanevsky, Estella ;

Schneider, Jingjing ;

Wang, Huei ;

Keech, Anthony ;

Pedersen, Terje R. ;

Sabatine, Marc S. ;

Sever, Peter S. ;

Robinson, Jennifer G. ;

Honarpour, Narimon ;

Wasserman, Scott M. ;

Ott, Brian R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :633-643

← 1 2 3 →